Deciphering the anti‑influenza potential of Eucommiae Cortex based on bioinformatics analysis: <em>In silico</em> and <em>in vitro</em> experiments

Nowakowska,Aleksandra; Kim,Minjee

doi:10.3892/etm.2025.12856

Deciphering the anti‑influenza potential of Eucommiae Cortex based on bioinformatics analysis: In silico and in vitro experiments

Authors:
- Aleksandra Nowakowska
- Minjee Kim
View Affiliations

Affiliations: Department of Biomedical Science and Engineering, Konkuk University Convergence Science and Technology Institute, Konkuk University, Seoul 05029, Republic of Korea
Published online on: March 27, 2025 https://doi.org/10.3892/etm.2025.12856
Article Number: 106

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Influenza infections damage the airway and induce the innate immune response that contributes to hyper‑inflammation. Eucommiae Cortex (EC) enhances immune function and suppresses inflammation. To determine potential compounds and targets of EC associated with influenza, bioinformatics analyses and experimental verification were employed. The active compounds of EC were retrieved from the Traditional Chinese Medicine Systems Pharmacology database. The intersecting targets of EC and influenza were determined and examined using network pharmacology to analyze the relationship between the compounds and disease targets. The network identified three main compounds (quercetin, genistein and kaempferol) and four main targets (IL6, BCL2, IL1B and TNF). The ligand‑target binding affinity was calculated by molecular docking, a computational method used in drug design to predict the interaction between the compound and protein target. The docking results revealed that kaempferol and TNF showed the strongest binding affinity. In vitro experiments confirmed the therapeutic effect of EC in influenza virus‑infected Madin‑Darby canine kidney cells. Collectively, the present study identified the active compounds and potential targets of EC in influenza and suggested EC as a future influenza treatment.

View Figures

View References

1	Sellers SA, Hagan RS, Hayden FG and Fischer WA: The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses. 11:372–393. 2017.PubMed/NCBI View Article : Google Scholar
2	Krammer F: The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol. 19:383–397. 2019.PubMed/NCBI View Article : Google Scholar
3	Bouvier NM and Palese P: The biology of influenza viruses. Vaccine. 26 (Suppl):D49–D53. 2008.PubMed/NCBI View Article : Google Scholar
4	Kim H, Webster RG and Webby RJ: Influenza virus: Dealing with a drifting and shifting pathogen. Viral immunol. 31:174–183. 2018.PubMed/NCBI View Article : Google Scholar
5	Li Y, Huo S, Yin Z, Tian Z, Huang F, Liu P, Liu Y and Yu F: The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs. mBio. 14(e0127323)2023.PubMed/NCBI View Article : Google Scholar
6	Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG and García-Sastre A: Influenza. Nat Rev Dis Primers. 4(3)2018.PubMed/NCBI View Article : Google Scholar
7	Zhao L, Yu X, Wu S, Xia K, Wang Y, Qin P, Huang Z, Kang C, Yuan Z and Li Y: Pharmacokinetic profiling and network pharmacology of honey-fried Licorice: An integrative workflow to study traditional Chinese medicines (TCMs). J Chromatogr B Analyt Technol Biomed Life Sci. 1:1248, 124353. 2024.PubMed/NCBI View Article : Google Scholar
8	Huai Y, Zhang WJ, Wang W, Dang K, Jiang SF, Li DM, Li M, Hao Q, Miao ZP, Li Y and Qian AR: Systems pharmacology dissection of action mechanisms for herbs in osteoporosis treatment. Chin Herb Med. 13:313–331. 2021.PubMed/NCBI View Article : Google Scholar
9	Zhu MQ and Sun RC: Eucommia ulmoides oliver: A potential feedstock for bioactive products. J Agric Food Chem. 66:5433–5438. 2018.PubMed/NCBI View Article : Google Scholar
10	Hussain T, Tan B, Liu G, Oladele OA, Rahu N, Tossou MC and Yin Y: Health-promoting properties of eucommia ulmoides: A review. Evid Based Complement Alternat Med. 2016(5202908)2016.PubMed/NCBI View Article : Google Scholar
11	Kim M, Park KH and Kim YB: Identifying active compounds and targets of Fritillariae thunbergii against influenza-associated inflammation by network pharmacology analysis and molecular docking. Molecules. 25(3853)2020.PubMed/NCBI View Article : Google Scholar
12	Hopkins AL: Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol. 4:682–690. 2008.PubMed/NCBI View Article : Google Scholar
13	Yu H, Chen J, Xu X, Li Y, Zhao H, Fang Y, Li X, Zhou W, Wang W and Wang Y: A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data. PloS One. 7(e37608)2012.PubMed/NCBI View Article : Google Scholar
14	Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, Ugwuja EI and Aja PM: Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 13(13398)2023.PubMed/NCBI View Article : Google Scholar
15	Pantsar T and Poso A: Binding affinity via docking: Fact and fiction. Molecules. 23(1899)2018.PubMed/NCBI View Article : Google Scholar
16	Reed LJ and Muench H: A simple method of estimating fifty per cent endpoints12. Am J Epidemiol. 27:493–497. 1938.
17	Tong X, Yang Y, Gong S, Han X, Wu Y and Ma X, Lang S, Ma J and Ma X: Data mining and network pharmacology analysis of kidney-tonifying herbs on the treatment of renal osteodystrophy based on the theory of ‘kidney governing bones’ in traditional Chinese medicine. Evid Based Complement Alternat Med. 30(1116923)2022.PubMed/NCBI View Article : Google Scholar
18	Feng S, Wang T, Fan L, An X, Ding X, Wang M, Zhai X, Cao Y, He J and Li Y: Exploring the potential therapeutic effect of Eucommia ulmoides-Dipsaci Radix herbal pair on osteoporosis based on network pharmacology and molecular docking technology. RSC Adv. 12:2181–2195. 2022.PubMed/NCBI View Article : Google Scholar
19	Ramos I and Fernandez-Sesma A: Modulating the innate immune response to influenza a virus: Potential therapeutic use of anti-inflammatory drugs. Front Immunol. 6(361)2015.PubMed/NCBI View Article : Google Scholar
20	Shi X, Zhou W, Huang H, Zhu H, Zhou P and Ju D: Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice. Crit Care. 17(R301)2013.PubMed/NCBI View Article : Google Scholar
21	Periferakis A, Tsigas G, Periferakis AT, Tone CM, Hemes DA, Periferakis K, Troumpata L, Badarau IA, Scheau C, Caruntu A, et al: Kaempferol: A review of current evidence of its antiviral potential. Int J Mol Sci. 24:2023.PubMed/NCBI View Article : Google Scholar
22	Liu AL, Wang HD, Lee SM, Wang YT and Du GH: Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg Med Chem. 16:7141–7147. 2008.PubMed/NCBI View Article : Google Scholar
23	Derksen A, Kühn J, Hafezi W, Sendker J, Ehrhardt C, Ludwig S and Hensel A: Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus. J Ethnopharmacol. 188:144–152. 2016.PubMed/NCBI View Article : Google Scholar
24	Kai H, Obuchi M, Yoshida H, Watanabe W, Tsutsumi S, Park YK, Matsuno K, Yasukawa K and Kurokawa M: In vitro and in vivo anti-influenza virus activities of flavonoids and related compounds as components of Brazilian propolis (AF-08). J Funct Foods. 8:214–223. 2014.
25	Li Z, Qu B, Wu X, Chen H, Wang J, Zhou L, Wu X and Zhang W: Methodology improvement for network pharmacology to correct the deviation of deduced medicinal constituents and mechanism: Xian-Ling-Gu-Bao as an example. J Ethnopharmacol. 289(115058)2022.PubMed/NCBI View Article : Google Scholar
26	Chua S, Tan HQ, Engelberg D and Lim LHK: Alternative experimental models for studying influenza proteins, host-virus interactions and anti-influenza drugs. Pharmaceuticals (Basel). 12(147)2019.PubMed/NCBI View Article : Google Scholar
27	Tsai HC, Lehman CW, Lin CC, Tsai SW and Chen CM: Functional evaluation for adequacy of MDCK-lineage cells in influenza research. BMC Res Notes. 12(101)2019.PubMed/NCBI View Article : Google Scholar
28	Kim M, Choi H, Kim S, Kang LW and Kim YB: Elucidating the effects of curcumin against influenza using in silico and in vitro approaches. Pharmaceuticals (Basel). 14(880)2021.PubMed/NCBI View Article : Google Scholar